Our Science Team
World-class researchers, doctors, and innovators driving breakthrough medical research and development

David Tsai
Ph.D
Founder & President Ambryx Biotechnology, Inc. Riverside, CA
Scientist Amgen Inc. Thousand Oaks, CA
Inventor of Protein Surface Ion Modification Technology
Senior Researcher of Oncology

Peter Britton
Ph.D
Founder and Board Chairman of Purecell Group
Co-inventor of UCF (Umbilical Cord Factors) global patent
International expert on translational cellular Regenerative Medicine

Yuan-Chuan Lee
Academy Professor, Johns Hopkins University, USA, 2011-present
Corresponding Professor, Genomics Research Center, Academia Sinica, 2016-present
Rosalind Kornfeld Award, Society of Glycobiology, 2011
American Society for Advancement of Science (AAAS) Fellow, 2016

Shiying Xiao
MD. Ph.D
Member of the Chinese Medicine Oncology Committee of the China Cancer Research Foundation
Former Deputy Director of the Biotechnology Center of the Ministry of Science and Technology
Editor of Drug Evaluation, World of Life, Journal of Modernization of Chinese Medicine, etc.
Senior Researcher of Oncology

Aihua Guo
MD. Ph.D
Researcher, Institute of Life Sciences, University of Aberdeen, UK
Postdoctoral Researcher, Durham University, UK
Honorary Senior Researcher, Galway Institute of Regenerative Medicine, Ireland
Former Director of Operations, China Regenerative Medicine International Co., Ltd Hong Kong
Published more than 20 papers in top international and domestic academic journals including Nature

Aimin Wang
Ph.D
Professor and Tutor of the doctoral program of Traditional Chinese Medicine in Gruber University 2001
Professor and Tutor of Traditional Chinese Medicine, Clinical Director, and Doctoral Supervisor in St. Luke's University 2004
6 times winner of China National or provincial scientific development awards
Senior Researcher in Chronic Disease Treatment Development

Liping Ren
MD.
Tutor of Nankai University School of Medicine
Researcher of City of Hope, University of Southern California, Medicine School of Nankai University, University of Weston School of Pharmacy, Fulgent Genetics
Chief Physician and CEO of Beijing Tongrentang Los Angeles Medical Center

Michael Borkin
NMD.
Considered the "Father of Naturopathic Endocrinology," Dr. Borkin was responsible for establishing the board specialty and authored the first National Board in Endocrinology for the American Naturopathic Medical Certification & Accreditation Board in Washington, DC. (2000)
Dr. Borkin has developed an international reputation for his extensive research and clinical experience in the areas of life extension and anti-aging. Dr. Borkin's emphasis on endocrine and neuro-transmitter regulation led to the development of unique non-invasive diagnostic and treatment protocols that dramatically increases both patient acceptance and treatment success rates.

Kevin Buckman
MD.
Dr. Buckman has over 38 years of hospital experience and has served on over 15 hospital committees for over 30 years, and he has served as Medical Director or Associate Director at Multiple Institutions. In May, 2018 he received the "Healing Hands Award."
His most recent Breast Cancer work was published at the International Cancer Conference and Forum 2010, in Seoul, Korea.
Leading Innovation in Healthcare
Our science team brings together decades of combined experience in biotechnology, regenerative medicine, oncology research, and clinical practice. With expertise spanning from protein engineering to naturopathic medicine, our team is dedicated to advancing healthcare through cutting-edge research and innovative therapeutic solutions.